Table 2.
Response to pemetrexed in the 2 cohorts.
| Variable | Exon 19 (n = 33) | Exon 21 (n = 22) |
|---|---|---|
| CR | — | — |
| PR | 11 | 5 |
| SD | 11 | 5 |
| PD | 6 | 5 |
| Not evaluable | 5 | 7 |
Response to pemetrexed in the 2 cohorts.
| Variable | Exon 19 (n = 33) | Exon 21 (n = 22) |
|---|---|---|
| CR | — | — |
| PR | 11 | 5 |
| SD | 11 | 5 |
| PD | 6 | 5 |
| Not evaluable | 5 | 7 |